首页> 外文期刊>Biological & pharmaceutical bulletin >The liquid culture filtrates of entomogenous fungus Paecilomyces tenuipes and its glycoprotein constituent protects against anemia in mice treated with 5-fluorouracil
【24h】

The liquid culture filtrates of entomogenous fungus Paecilomyces tenuipes and its glycoprotein constituent protects against anemia in mice treated with 5-fluorouracil

机译:虫源性真菌拟青霉的液体培养物滤液及其糖蛋白成分可预防5-氟尿嘧啶治疗的小鼠贫血

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of the present study was to investigate the efficacy of a liquid culture filtrates of the entomogenous fungus Paecilomyces tenuipes (PTCF) and its main active glycoprotein-enriched (PGF) fraction against hematotoxicity in mice treated with 5-fluorouracil (5-FU). Oral administration of PTCF (100 mg/kg/d) for 7 consecutive days after 5-FU injection significantly suppressed reductions in the red and white blood cell counts in peripheral blood, and accelerated their recoveries. From PTCF, glycoprotein-enriched fraction (PGF, >90% protein, approximately 15 kDa determined by SDS-PAGE) was separated as active ingredient that ameliorates 5-FU-induced anemia. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis of trypsinized-PGF showed 11 fragment ion peaks. Effective recoveries of erythrocytopenia and leukocytopenia were observed when PGF was co-administered with murine recombinant erythropoietin (mrEPO; 5 U/mouse). Oral administration of PGF also inhibited 5-FU-induced decreases in peripheral reticulocyte and bone marrow cell counts on day 12, and markedly hastened their recoveries on day 20, in dose-dependent manners. Reductions in erythroid progenitor colonies, such as colony-forming units (CFU)-erythroid and burst-forming units-erythroid mix, formed by bone marrow cells from 5-FU-treated mice were markedly improved by oral administration of PGF with subcutaneous mrEPO. Oral administration of PGF also increased the myeloid lineage progenitor, CFU-granulocyte-macrophages, in cultured bone marrow cells. These findings suggest that PGF isolated from P tenuipes has the potential to protect against 5-FU-inudced erythrocytopenia and leukopenia, especially in combination with mrEPO, and also has hematopoietic activity, through stimulation of immature erythroid as well as myeloid progenitor cell differentiation.
机译:本研究的目的是研究在用5-氟尿嘧啶(5-FU)处理的小鼠中,虫源性真菌拟青霉(PTCF)及其主要活性糖蛋白富集(PGF)的液体培养物滤液对血液毒性的功效。 。 5-FU注射后连续7天口服PTCF(100 mg / kg / d)可以显着抑制外周血中红细胞和白细胞计数的减少,并加速其恢复。从PTCF中分离出富含糖蛋白的馏分(PGF,> 90%的蛋白质,通过SDS-PAGE测定约为15 kDa)作为改善5-FU引起的贫血的活性成分。胰蛋白酶消化的PGF的基质辅助激光解吸/电离飞行时间质谱分析显示了11个碎片离子峰。当PGF与鼠类重组促红细胞生成素(mrEPO; 5 U /小鼠)联合使用时,观察到红细胞减少和白细胞减少的有效恢复。在第12天,口服PGF还可以抑制5-FU诱导的外周网织红细胞和骨髓细胞计数的减少,并在20天以剂量依赖的方式显着加快其恢复。通过皮下注射mrEPO口服PGF,可以显着改善由5-FU处理的小鼠的骨髓细胞形成的类红细胞祖细胞集落,如集落形成单位(CFU)-类红血球和爆发形成单位-类红血球混合物。口服PGF还可以在培养的骨髓细胞中增加髓系谱系祖细胞CFU-粒细胞-巨噬细胞。这些发现表明,从P型腱索中分离出的PGF具有预防5-FU诱导的红细胞减少症和白细胞减少症的潜力,特别是与mrEPO联合使用时,还具有通过刺激未成熟的类红细胞以及骨髓祖细胞分化而具有造血活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号